View this email in your browser

Dear <<First Name (optional)>>,

Shockingly, while more than 50% of people have been fully vaccinated against COVID-19 in many high-income countries, that number drops to less than 3% of people in countries in Africa who have been fully vaccinated to date.  

A handful of pharmaceutical corporations control the vaccine technology and its production and supply, even though governments contributed billions in public money to the research and development (R&D) of these vaccines. 

Imagine the difference it could make if African countries currently facing waves of COVID-19 didn´t have to rely on imports or donations of vaccines: they could produce them themselves.  

Learn what you can do to urge BioNTech, Pfizer and Moderna to share the vaccine technology and save lives

If the pharma companies BioNTech, Pfizer and Moderna shared their mRNA vaccine technology and know-how with other manufacturers, we could turn this vaccine inequity around. 

We have already identified more than seven manufacturers in African countries, who could start production of mRNA vaccines, if BioNTech, Pfizer or Moderna shared technology with them.  

Call on pharma companies BioNTech, Pfizer and Moderna to #ShareTheTech
This is why MSF is calling for technology transfer from the pharma corporations to the World Health Organization (WHO) COVID-19 mRNA Vaccine Technology Transfer Hub, based in South Africa. 

By creating sustainable production and supply of new vaccines in places where need is greatest, we can reach equitable access to COVID-19 vaccines for all. 

Click the button to demand BioNTech, Pfizer and Moderna share COVID-19 vaccine technology to save lives.
Thank you, 

MSF Access Campaign team
← Read more about our work on our Medium blog

2021 MSF Access Campaign, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.